San Francisco, CA, United States of America

C Randell Brown


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal1 out of 832,812 
Other
 patents

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of C Randell Brown in Genetic Correction

Introduction

C Randell Brown, based in San Francisco, CA, has made significant strides in the field of genetic research and therapy. With one patent to his name, Brown is an inventor who focuses on corrective methods for genetic defects caused by conformationally defective proteins. His work has implications for treating various genetic disorders, including cystic fibrosis.

Latest Patents

C Randell Brown holds a patent titled "Correction of Genetic Defects Using Chemical Chaperones." This groundbreaking invention outlines methods for improving phenotypic defects related to misfolded proteins. The patent describes utilizing protein stabilizing agents like dimethylsulfoxide (DMSO), deuterated water, and trimethylamine N-oxide (TMAO) to enhance the functionality of defective proteins. Specifically, it addresses the cystic fibrosis transmembrane conductance regulator (CFTR) protein and prion proteins, offering promising avenues for medical treatment and research.

Career Highlights

Brown's career is marked by his dedication to innovation in genetic therapies. His patent reflects a deep understanding of protein folding and the conditions that arise from improper protein processing. Through his work, Brown has positioned himself as a thought leader in the intersection of biotechnology and therapeutic advancements, aiming to improve the quality of life for individuals with genetic conditions.

Collaborations

C Randell Brown has collaborated with distinguished colleagues, including William J. Welch and Jorg Tatzelt. These partnerships underline the collaborative nature of scientific research, contributing to a stronger foundation of knowledge in the field of genetic therapy. Together, they strive to advance the understanding of protein stabilization and its potential therapeutic applications.

Conclusion

C Randell Brown's innovative approach to correcting genetic defects illustrates the power of biotechnology in addressing complex health issues. With his patent on using chemical chaperones, Brown contributes significantly to the ongoing pursuit of effective treatments for genetic disorders. His work exemplifies the intersection of collaboration, innovation, and the quest for scientific advancement in improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…